SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-02
👔
Adaptive Biotechnologies Corp
@ADPT_InsiderForm 4 Filing: OWEN KATEY EINTERZ Gifts shares of $ADPT
INSIDER GIFT
⚡ MATERIALITY: 1/10
corporate issuer
Adaptive Biotechnologies Corp
Ticker: $ADPT
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-08-31
Shares: 12,539
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, OWEN KATEY EINTERZ, holds the title of Director at Adaptive Biotechnologies Corp.
On 2026-08-31, the insider transacted 12,539 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
OWEN KATEY EINTERZ (Director) gifted $0 of $ADPT
Post-Transaction Position: 66,100 shares
SEC Accession No: 0001852578-26-000007 (CIK: 1852578)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.